In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Tepid Wedding, Now A Possible Divorce

Executive Summary

The year-old union of bioMerieux-Pierre Fabre appears to be on the verge of disintegrating, amid lack of a coherent strategy, disagreements between the two founders who spearheaded the deal, and departure of key top executives. The company won't comment except to say that it is considering various alternatives including a break-up. Unraveling should not be difficult, since the two companies haven't integrated much. And the separation would leave bioMerieux, now the world's eighth largest diagnostics company, and Pierre Fabre, one of France's largest independent pharmaceutical companies, free to seek more appropriate solutions to the challenges they face.
Advertisement

Related Content

Pierre Fabre: Time to Reap R&D Rewards In-House
Pierre Fabre: Time to Reap R&D Rewards In-House
bioMerieux, a Family-Owned French Firm, Finally Goes Public
bioMerieux, a Family-Owned French Firm, Finally Goes Public
Roche/Chugai Blaze a Trail...But Will Anyone Follow?
bioMerieux-Pierre Fabre Lives Up to Its Name
bioMerieux Pushes Ahead in Genomics
Gen-Probe's DNA Play
Focused Consolidator: bioMerieux
Roche Solves BM's Strategic Dilemma

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001822

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel